Mordechai. Sokolovsky

Mordechai. Sokolovsky's AcademicInfluence.com Rankings

Chemistry

#2884

World Rank

#3853

Historical Rank

Organic Chemistry

#447

World Rank

#522

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Mordechai. Sokolovsky's Degrees

PhD Chemistry University of California, Berkeley

Why Is Mordechai. Sokolovsky Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Mordechai. Sokolovsky's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Tetranitromethane. A reagent for the nitration of tyrosyl residues in proteins. (1966) (538)
Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. (1988) (353)
Conversion of 3-nitrotyrosine to 3-aminotyrosine in peptides and proteins. (1967) (207)
Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker. (1989) (173)
Environmentally sensitive tyrosyl residues. Nitration with tetranitromethane. (1967) (167)
Similarities in mode and sites of action of sarafotoxins and endothelins. (1989) (151)
Competitive interaction between endothelin and sarafotoxin: Binding and phosphoinositides hydrolysis in rat atria and brain. (1989) (143)
Psychotomimetics as anticholinergic agents. I. 1-Cyclohexylpiperidine derivatives: anticholinesterase activity and antagonistic activity to acetylcholine. (1974) (138)
Endothelin receptor subtypes and their role in transmembrane signaling mechanisms. (1995) (137)
Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke. (1997) (132)
A novel subtype of endothelin receptors. (1992) (121)
Tetranitromethane. A Reagent for the Nitration of Tyrosine and Tyrosyl Residues of Proteins1 (1966) (121)
Kinetic characterization of the phencyclidine-N-methyl-D-aspartate receptor interaction: evidence for a steric blockade of the channel. (1988) (105)
Characterization of muscarinic acetylcholine receptors from mouse brain: evidence for regional heterogeneity and isomerization. (1979) (100)
Three apparent receptor subtypes for the endothelin/sarafotoxin family (1989) (100)
Endothelins and sarafotoxins: physiological regulation, receptor subtypes and transmembrane signaling. (1992) (99)
Muscarinic receptors in the central nervous system. (1984) (96)
Amitriptyline: Long-term treatment elevates α-adrenergic and muscarinic receptor binding in mouse brain (1980) (92)
Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: subunit assembly may explain high- and low-affinity agonist states. (1983) (91)
The reaction of diazonium-1H-tetrazole with proteins. Determination of tyrosine and histidine content. (1966) (90)
Human Pancreatic Proteolytic Enzymes and Protein Inhibitors (1974) (85)
INDUCED ACETYLCHOLINE RELEASE FROM ACTIVE PURELY CHOLINERGIC TORPEDO SYNAPTOSOMES 1 (1978) (78)
Muscarinic receptor binding in mouse brain: regulation by guanine nucleotides. (1980) (78)
Chemical Interactions between Lysine and Dehydroalanine in Modified Bovine Pancreatic Ribonuclease (1964) (76)
Mode of binding of [3H]dibenzocycloalkenimine (MK‐801) to the N‐methyl‐D‐aspartate (NMDA) receptor and its therapeutic implication (1988) (74)
Mechanism of acetylcholine release: possible involvement of presynaptic muscarinic receptors in regulation of acetylcholine release and protein phosphorylation. (1979) (73)
The functional tyrosyl residues of carboxypeptidase A. Nitration with tetranitromethane. (1967) (73)
Reaction of tetranitromethane with sulfhydryl groups in proteins. (1969) (71)
The interaction of bis-pyridinium oximes with mouse brain muscarinic receptor. (1980) (69)
Nonenzymatic Cleavages of Peptide Chains at the Cysteine and Serine Residues through their Conversion into Dehydroalanine. I. Hydrolytic and Oxidative Cleavage of Dehydroalanine Residues (1964) (69)
Muscarinic acetylcholine receptors interactions: competition binding studies with agonists and antagonists (1977) (66)
Cloned M1 muscarinic receptors mediate both adenylate cyclase inhibition and phosphoinositide turnover. (1988) (63)
A model for substrate binding and kinetics of carboxypeptidase A. (1968) (63)
Psychotomimetic drugs as anticholinergic agents. II. Quantum-mechanical study of molecular interaction potentials of 1-cyclohexylpiperidine derivatives with the cholinergic receptor. (1973) (63)
Tricyclic antidepressants as antimuscarinic drugs: in vivo and in vitro studies. (1977) (62)
Functional endothelin/sarafotoxin receptors in rat heart myocytes: structure-activity relationships and receptor subtypes. (1989) (59)
Agonist-specific reverse regulation of muscarinic receptors by transition metal ions and guanine nucleotides. (1980) (59)
Structure‐Function Relationships of Endothelins, Sarafotoxins, and Their Receptor Subtypes (1992) (58)
Blockade of45Ca2+ influx through theN-methyl-d-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211 (1993) (58)
Functional endothelin/sarafotoxin receptors in the rat uterus. (1989) (58)
Studies on muscarinic acetylcholine receptors from mouse brain: Characterization of the interaction with antagonists (1978) (57)
Modification of Arginyl Residues in Porcine Carboxypeptidase B (1975) (56)
Anticholinesterase and antiacetylcholine activity of 1-phenylcyclohexylamine derivatives. (1977) (55)
Agonist and antagonist binding to rat brain muscarinic receptors: Influence of aging (1987) (54)
Endothelin receptors stimulate both phospholipase C and phospholipase D activities in different cell lines. (1993) (53)
Multiple binding sites of tricyclic antidepressant drugs to mammalian brain receptors (1978) (52)
Studies on muscarinic receptors in mouse and rat hypothalamus: a comparison of sex and cyclical differences. (1981) (51)
The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-Δ 6-tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates N-methyl-d-aspartate receptor-mediated neurotoxicity in primary cultures of rat forebrain (1993) (50)
1-Aminocyclopropane-1-carboxylic acid (ACC) mimics the effects of glycine on the NMDA receptor ion channel. (1988) (50)
N-acetyl-(L-Ala) 3 -p-nitroanilide as a new chromogenic substrate for elastase. (1973) (49)
Chemically modified nylons as supports for enzyme immobilization (1974) (48)
Functional Coupling of G Proteins to Endothelin Receptors Is Ligand and Receptor Subtype Specific (2000) (47)
Characterization and localization of a novel neuroreceptor for the peptide sarafotoxin. (1988) (46)
High affinity binding of [3H]acetylcholine to muscarinic receptors. Regional distribution and modulation by guanine nucleotides. (1985) (46)
The Glycine Site of the N‐Methyl‐D‐Aspartate Receptor Channel: Differences Between the Binding of HA‐966 and of 7‐Chlorokynurenic Acid (1990) (45)
Purification and crystallization of human carboxypeptidase A. (1976) (45)
Denervation, supersensitivity and muscarinic receptors in the cat iris. (1979) (45)
Dual pathways in muscarinic receptor stimulation of phosphoinositide hydrolysis. (1987) (44)
Azocarboxypeptidase: functional consequences of tyrosyl and histidyl modification. (1967) (43)
On the interaction of drugs with the cholinergic nervous system--V. Characterization of some effects induced by physostigmine in mice: in vivo and in vitro studies. (1978) (41)
Endothelins and sarafotoxins: physiological regulation, receptor subtypes and transmembrane signaling. (1991) (39)
Biochemical characterization and sex dimorphism of muscarinic receptors in rat adenohypophysis. (1981) (39)
G-protein mediates voltage regulation of agonist binding to muscarinic receptors: effects on receptor-Na+ channel interaction. (1988) (38)
On the interaction of drugs with the cholinergic nervous system--III. Tolerance to phencyclidine derivatives: in vivo and in vitro studies. (1977) (38)
Bisquaternary pyridinium oximes as allosteric inhibitors of rat brain muscarinic receptors. (1985) (37)
Central muscarinic receptor degeneration following 6-hydroxydopamine lesion in mice. (1979) (37)
N-methyl-D-aspartate/phencyclidine receptor complex of rat forebrain: purification and biochemical characterization. (1990) (37)
Endothelins and sarafotoxins: receptor heterogeneity. (1994) (37)
Cholinolytic action of phencyclidine derivatives. (1974) (36)
Endothelin/sarafotoxin receptor induced phosphoinositide turnover: effects of pertussis and cholera toxins and of phorbol ester. (1990) (35)
Endothelin/sarafotoxin receptor heterogeneity: evidence for different glycosylation in receptors from different tissues. (1991) (35)
Reaction of tetranitromethane with tryptophan and related compounds (1970) (35)
Molecular regulation of receptors: interaction of beta-estradiol and progesterone with the muscarinic system. (1981) (35)
Kinetics of Choline Uptake into Isolated Rat Forebrain Microvessels: Evidence of Endocrine Modulation (1988) (35)
Cooperativity pattern in the interaction of the antiestrogen drug clomiphene with the Muscarinic receptors. (1982) (35)
[20] Carboxypeptidases A and B (1977) (34)
Binding studies and photoaffinity labeling identify two classes of phencyclidine receptors in rat brain. (1987) (34)
Evidence for involvement of the voltage-dependent Na+ channel gating in depolarization-induced activation of G-proteins. (1993) (34)
On the Synthesis of Cysteine Peptides (1964) (34)
Disturbances in the cardiovascular system caused by endothelin and sarafotoxin. (1989) (33)
Distinctive structural requirement for the binding of uncompetitive blockers (phencyclidine-like drugs) to the NMDA receptor. (1990) (33)
Acetylcholine-like molecular arrangement in psychomimetic anticholinergic drugs. (1973) (33)
A theoretical and experimental study of the semirigid cholinergic agonist 3-acetoxyquinuclidine. (1975) (32)
Interactions between the muscarinic receptors, sodium channels, and guanine nucleotide-binding protein(s) in rat atria. (1986) (32)
Chemical approaches to the study of enzymes (1971) (32)
Water-insoluble derivatives of naringinase (1971) (32)
Sarafotoxin receptors mediate phosphoinositide hydrolysis in various rat brain regions (1989) (32)
Nitrocytochrome c. I. Structure and enzymic properties. (1970) (32)
Interaction of the antiarrhythmic drug amiodarone with the muscarinic receptor in rat heart and brain. (1984) (32)
Bisquaternary Pyridinium Oximes as Presynaptic Agonists and Postsynaptic Antagonists of Muscarinic Receptors (1986) (31)
Role of lipids in age-related changes in the properties of muscarinic receptors in cultured rat heart myocytes. (1986) (31)
Contractile effects and binding properties of endothelins/sarafotoxins in the guinea pig ileum. (1991) (31)
Single-step isolation and resolution of pancreatic carboxypeptidases A and B. (1979) (31)
Solubilization of muscarinic acetylcholine receptor by zwitterionic detergent from rat brain cortex. (1982) (31)
Neurotransmitter release from viable purely cholinergic Torpedo synaptosomes. (1976) (30)
Endothelin receptor heterogeneity, G-proteins, and signaling via cAMP and cGMP cascades (1995) (30)
Batrachotoxin changes the properties of the muscarinic receptor in rat brain and heart: possible interaction(s) between muscarinic receptors and sodium channels. (1985) (29)
Regional heterogeneity of muscarinic receptors of mouse brain (1979) (28)
Ligand-specific stimulation/inhibition of cAMP formation by a novel endothelin receptor subtype. (1994) (28)
Interaction of phencyclidine and its new adamantyl derivatives with muscarinic receptors. (1980) (27)
Cloned rat M3 muscarinic receptors mediate phosphoinositide hydrolysis but not adenylate cyclase inhibition (1988) (27)
Solubilization of Rat Brain Phencyclidine Receptors in an Active Binding Form That Is Sensitive to N‐Methyl‐d‐Aspartate Receptor Ligands (1988) (27)
Cyclic GMP formation in rat cerebellar slices is stimulated by endothelins via nitric oxide formation and by sarafotoxins via formation of carbon monoxide. (1994) (27)
Characterization of the presynaptic muscarinic receptor in synaptosomes of torpedo electric organ by means of kinetic and equilibrium binding studies (1980) (26)
Porcine carboxypeptidase B. Nitration of the functional tyrosyl residue with tetranitromethane. (1972) (26)
Functional coupling between endothelin receptors and multiple G-proteins in rat heart myocytes. (1993) (26)
Nitrocytochrome c. II. Spectroscopic properties and chemical reactivity. (1970) (25)
Muscarinic cholinergic receptors and their interactions with drugs (1989) (25)
STRUCTURE-ACTIVITY RELATIONSHIP OF SOME PHENCYCLIDINE DERIVATIVES- IN VIVO STUDIES IN MICE (1978) (25)
Muscarinic mechanisms and sex hormone secretion in rat adenohypophysis and preoptic area. (1982) (25)
Depolarization-induced changes in the muscarinic receptor in rat brain and heart are mediated by pertussis-toxin-sensitive G-proteins. (1991) (25)
Localization of phencyclidine binding sites on alpha and beta subunits of the nicotinic acetylcholine receptor from Torpedo ocellata electric organ using azido phencyclidine (1984) (24)
Biochemical characterization of muscarinic receptors. (1980) (24)
Copper ions and diamide induce a high affinity guanine-nucleotide-insensitive state for muscarinic agonists. (1984) (23)
Recognition of the muscarinic receptor by its endogenous neurotransmitter: binding of [3H]acetylcholine and its modulation by transition metal ions and guanine nucleotides. (1984) (23)
Induced interconversion of agonist affinity states in muscarinic receptor from mice brain: effects of temperature and sugars. (1980) (23)
Rate constants of agonist binding to muscarinic receptors in rat brain medulla. Evaluation by competition kinetics. (1985) (23)
Reactive oxygen species regulate signaling pathways induced by M1 muscarinic receptors in PC12M1 cells (2001) (23)
Acetylcholine rhythm in the preoptic area of the rat hypothalamus is synchronized with the estrous cycle (1986) (23)
Identification of muscarinic receptors in the torpedo electric organ (1978) (23)
Enzymatic resolution and cholinergic properties of (+/-)3-quinuclidinol derivatives. (1977) (22)
Allosteric Interactions of Muscarinic Receptors and Their Regulation by Other Membrane Proteins (1989) (22)
Expression of muscarinic binding sites in primary human brain tumors. (1984) (22)
Aging of rat heart myocytes disrupts muscarinic receptor coupling that leads to inhibition of cAMP accumulation and alters the pathway of muscarinic-stimulated phosphoinositide hydrolysis. (1989) (22)
Cross-linking of endothelin 1 and endothelin 3 to rat brain membranes: identification of the putative receptor(s). (1990) (21)
Species differences determine azido phencyclidine labeling pattern in desensitized nicotinic acetylcholine receptors. (1983) (21)
Basic and non-basic substrates of carboxypeptidase B. (1973) (21)
BQ-123 identifies heterogeneity and allosteric interactions at the rat heart endothelin receptor. (1993) (20)
Interactions of quinidine and lidocaine with rat brain and heart muscarinic receptors. (1985) (20)
Regional heterogeneity of two high affinity binding sites for 3H-WB-4101 in mouse brain. (1980) (20)
Muscarinic antagonists induce different receptor conformations in rat adenohypophysis. (1983) (20)
Affinity labeling of muscarinic receptors in rat cerebral cortex with a photolabile antagonist. (1982) (19)
Altered ontogenesis of muscarinic cholinergic receptor in mouse brain: effect of L-thyroxine and betamethasone. (1981) (19)
Endothelin‐1 receptors in the human myometrium: evidence for different binding properties in post‐menopausal as compared to premenopausal and pregnant women (1993) (19)
Muscarinic acetylcholine receptors in albino rabbit iris-ciliary body. (1979) (19)
Functional evidence for a second binding site of nicotinic antagonists using phencyclidine derivatives. (1979) (19)
Increased agonist affinity is induced in tetranitromethane-modified muscarinic receptors. (1985) (18)
Reduction of nitrotyrosyl residues in proteins. (1971) (18)
Functional role for glycosylated subtypes of rat endothelin receptors. (1998) (18)
Analysis of ligand binding to receptors by competition kinetics. Application to muscarinic antagonists in rat brain cortex. (1985) (17)
Porcine carboxypepticase B: multiple substrates binding modes. (1972) (17)
On the regulation of acetylcholine release: a study utilizing Torpedo synaptosomes and synaptic vesicles. (1980) (17)
Identification of polypeptides of the phencyclidine receptor of rat hippocampus by photoaffinity labeling with [3H]azidophencyclidine. (1986) (17)
On the use of tetranitromethane as a nitration reagent for tyrosyl residues (1970) (16)
Primary structure of cytochrome c from the camel, Camelus dromedarius. (1972) (16)
Metallocarboxypeptidases: a cadmium-carboxypeptidase B with peptidase activity. (1973) (16)
Acetylcholine in the rat pituitary: a possible humoral factor (1988) (16)
Modulation of the voltage-dependent sodium channel by agents affecting G-proteins: a study in Xenopus oocytes injected with brain RNA (1989) (15)
Affinity labelling of carboxypeptidase B: modification of a methionyl residue. (1974) (15)
In vivo and in vitro studies on the antimuscarinic activity of some amino esters of benzilic acid. (1978) (15)
Muscarinic binding to mouse brain receptor sites. (1978) (15)
Chemical evidence for a functional arginine residue in carboxypeptidase B. (1972) (15)
Postnatal changes in muscarinic receptor subtype mRNAs in rat brain and heart. (1989) (15)
Different pathways of endothelin/sarafotoxin-stimulated phosphoinositide hydrolysis in myocytes. (1990) (15)
Nitration of Pepsin, Thrombin and Carboxypeptidase B with Tetranitromethane† (1969) (15)
Biochemical studies on muscarinic receptors (1981) (14)
Heterogeneity of solubilized muscarinic cholinergic receptors: binding and hydrodynamic properties. (1985) (14)
Endothelin receptors in rat cerebellum: activation of phosphoinositide hydrolysis is transduced by multiple G-proteins. (1993) (14)
Guanine nucleotides preferentially inhibit binding of antagonists (male) and agonists (female) to muscarinic receptors of rat adenohypophysis. (1981) (14)
Muscarinic acetylcholine receptors in cat iris. (1979) (14)
Nonenzymatic Cleavage of Peptide Bonds: The Half-cystine Residues in Bovine Pancreatic Ribonuclease (1964) (14)
Disopyramide and Quinidine Bind with Inverse Selectivity to Muscarinic Receptors in Cardiac and Extracardiac Rat Tissues (1985) (13)
Porcine carboxypeptidase B. I. Affinity chromatography and specificity. (1971) (13)
Muscarinic involvement in the regulation of gonadotropin-releasing hormone in the cyclic rat (1992) (13)
Isonitrile derivatives of polysaccharides as supports for the covalent fixation of proteins and other ligands. (1979) (13)
A model for the interaction of muscarinic receptors, agonists, and two distinct effector substances. (1990) (13)
Endothelin-1 receptors on the human placenta and fetal membranes: evidence for different binding properties in pre-eclamptic pregnancies. (1993) (13)
Muscarinic receptor heterogeneity revealed by interaction with bretylium tosylate. Different ligand-receptor conformations versus different receptor subclasses. (1985) (12)
Peptide inhibitors and activators of carboxypeptidase B. (1973) (12)
Endothelins and Sarafotoxins: Effects on Motility, Binding Properties and Phosphoinositide Hydrolysis During the Estrous Cycle of the Rat Uterus (1992) (12)
Immunological and structural characterization of sarafotoxin/endothelin family of peptides. (1989) (12)
Multilayer immobilized‐enzyme filter reactors: Urease bound to nylon fabric filters (1979) (12)
Multiple mode of binding of phencyclidines: high affinity association between phencyclidine receptors in rat brain and a monovalent ion-sensitive polypeptide. (1987) (12)
Porcine carboxypeptidase B. Arsanilazocarboxypeptidase, spectral and functional consequences of modification of tyrosine-"248". (1972) (12)
Involvement of Nuclear Factor-κB in Endothelin-A-Receptor–Induced Proliferation and Inhibition of Apoptosis (2001) (12)
Allosteric interactions between muscarinic agonist binding sites and effector sites demonstrated by the use of bisquaternary pyridinium oximes. (1985) (12)
Synthetic peptides related to horse heart cytochrome c. VII. Synthesis and inhibitory properties of the 70-80 undecapeptide. (1972) (11)
Guanosine 5'-triphosphate binding protein (Gi) and two additional pertussis toxin substrates associated with muscarinic receptors in rat heart myocytes: characterization and age dependency. (1988) (11)
Localization of azidophencyclidine-binding site on the nicotinic acetylcholine receptor alpha-subunit. (1987) (11)
Regional heterogeneity of rat brain phencyclidine (PCP) receptors revealed by photoaffinity labeling with [3H] azido phencyclidine. (1985) (11)
Characterization of the interaction of phencyclidine and its derivatives with the ionic channel of the nicotinic receptor. (1983) (11)
Affinity labeling of receptors. (1977) (11)
Interaction of Bretylium Tosylate with Rat Cardiac Muscarinic Receptors: Possible Pharmacological Relevance to Antiarrhythmic Action (1984) (11)
Chemically modified nylons as supports for enzyme immobilization (1976) (11)
Cholinergic nerve terminals contain ascorbic acid which induces Ca2+‐dependent release of acetylcholine and ATP from isolated Torpedo synaptic vesicles (1979) (11)
Reversible and irreversible inhibition of rat brain muscarinic receptors is related to different substitutions on bisquaternary pyridinium oximes (1985) (10)
Biochemical characterization of the muscarinic receptors. (1980) (10)
A theoretical model study of the comparative effectiveness of atropine and scopolamine action in the central nervous system. (1977) (10)
Photoaffinity labeling reveals two muscarinic receptor macromolecules associated with the presence of calcium in rat adenohypophysis (1982) (10)
Carboxypeptidases A and B. (1977) (10)
Nitration of horse heart ferricytochrome C with tetranitromethane (1969) (10)
Nuclear-magnetic-resonance studies of carboxypeptidase B. Binding of inhibitors to the manganese enzyme. (1975) (9)
Inhibition of pertussis toxin catalyzed ADP-ribosylation of G-proteins by membrane depolarization in rat brain synaptoneurosomes (1991) (9)
Effect of Ca2+ on the binding characteristics of muscarinic receptors in rat adenohypophysis--variation during the estrous cycle. (1985) (9)
Human pancreatic proteolytic enzymes and protein inhibitors. Isolation and molecular properties. (1974) (9)
The role of a tyrosyl residue in the mechanism of action of carboxypeptidase B: luminescence studies. (1973) (9)
Factors required for calcium dependent acetylcholine release from isolated torpedo synaptic vesicles. (1978) (9)
Paradoxical signal transduction mechanism of endothelins and sarafotoxins in cultured pituitary cells: Stimulation of phosphoinositide turnover and inhibition of prolactin release (1992) (9)
On the interaction of drugs with the cholinergic nervous system (1977) (8)
Divergent Regulation of Muscarinic Binding Sites and Acetylcholinesterase in Discrete Regions of the Developing Human Fetal Brain (1986) (8)
cGMP formation in rat atrial slices is ligand and endothelin receptor subtype specific. (1996) (8)
Rat brain and heart muscarinic receptors: modification with tetranitromethane. (1985) (8)
Characterization of Drug Reactivity in Cholinergic Systems by Molecular Interaction Potentials (1974) (8)
Interactions between antagonist‐occupied muscarinic binding sites in rat adenohypophysis (1982) (7)
On the interaction of esters and peptides with carboxypeptidase B. (1975) (7)
Computerized localization of peptides in proteins of known sequence (1971) (7)
Temperature dependence of agonist binding to muscarinic receptors in rat hypothalamic regions. (1981) (6)
Chemical Approaches to the Mode of Action of Carboxypeptidase B (1974) (6)
On the interaction of drugs with the cholinergic nervous system (1977) (6)
On the interaction of drugs with the cholinergic nervous system (1978) (6)
Affinity chromatography of carboxypeptidase B. (1974) (6)
141. Synthesis of benzoselenopheno[2,3-b]benzoselenophens from 1,1-diarylethylenes and selenium oxychloride (1962) (6)
Modulation of glutamate-induced uncompetitive blocker binding to the NMDA receptor by temperature and by glycine. (1990) (6)
Impaired binding properties of endothelin‐1 receptors in human endometrial carcinoma tissue (1993) (6)
Antibodies to muscarinic acetylcholine receptors in myasthenia gravis. (1982) (6)
Photoaffinity labeling of muscarinic receptors. (1987) (5)
Photoreactions of phosphorothioate and cysteamine-S-phosphate. Photosubstitution and photophosphoryl transfer. (1975) (5)
Metal—tyrosyl interaction in carboxypeptidases: Phosphorescence studies (1975) (5)
Neurotoxicity of dipiperidinoethane due to in vivo conversion to a selective cholinesterase inhibitor (1985) (5)
Carboxyl residue(s) at the ligand-binding site of rat muscarinic receptors. (1988) (5)
Beef-liver arginase. Isolation and molecular properties. (1972) (5)
CHOLINERGIC URTICARIA, COPPER-INDUCED HYPERSENSITIVITY, AND MUSCARINIC RECEPTORS (1983) (5)
Involvement of tyrosyl residue(s) in binding of endothelin and sarafotoxin to their receptors in rat brain and heart (1992) (5)
Limited proteolysis of horse heart cytochrome c. (1971) (4)
Application of phosphorescence to the study of proteins. (1978) (4)
Cross talk between receptors: muscarinic receptors, sodium channels, and guanine nucleotide-binding protein(s) in rat membrane preparations and synaptoneurosomes. (1988) (4)
Sarafotoxins and Their Relationship to the Endothelin Family of Peptides (2001) (4)
Proteolytic proenzymes in the pancreas in the course of experimental bile-induced pancreatitis in the guinea pig. (1978) (4)
Chemical modification of rat cerebral cortex M1 muscarinic receptors: role of histidyl residues in antagonist and agonist binding. (1988) (4)
Interactions between Ca2+-antagonist binding sites in rat adenohypophysis: dependence on estrous cycle. (1984) (4)
On the interaction of drugs with the cholinergic nervous system. VI. Tolerance to physostigmine in mice. (1977) (3)
Derivatized Nylon: A New Support for the Immobilization of Enzymes (1974) (3)
Isolation of Human Pancreatic Inhibitor and the Study of Its Interaction with Mammalian and Human Proteases (1974) (3)
Solubilization of endothelin/sarafotoxin receptors in an active binding form. (1989) (3)
Structure-activity relationship in a new series of atropine analogues. 1. N,N'-Disubstituted 6,7-diazabicyclo[3.2.2]nonane derivatives. (1979) (3)
Competitive Inhibition of Acetylcholinesterase by Bretylium: Possible Mechanism for its Induction of Norepinephrine Release (1985) (2)
Antimuscarinic properties of antidepressants: Dibenzepin (Noveril®) (1977) (2)
Proceedings: Carboxypeptidase B: modification of functional arginyl residues. (1975) (2)
Chapter 9 – AFFINITY AND PHOTOAFFINITY LABELING OF RECEPTORS (1984) (2)
Evidence for an endogenous factor involved in maintenance of pirenzepine high-affinity binding in rat brain stem. (1988) (2)
Isolation, Properties and Partial Sequence of the Cytochrome C of the Camel, Camelus Dromedarius (1972) (2)
Estrous Cycle Dependent Modulation of Muscarinic Cholinergic Receptors in the Hypothalamus and Adenohypophysis (1984) (2)
Chapter 10 – Chemically Modified Polymers Containing Isocyanide Functional Groups as Supports for Enzyme Immobilization (1977) (2)
Exhaustive Proteolysis of Derivatives of Lysozyme (1971) (1)
Metal ion effects on target sites of modification in metallocarboxypeptidase B. (1983) (1)
Application of competition kinetics to investigate rat brain muscarinic receptors. (1987) (1)
Characterization of membranal and purified NMDA receptors. (1990) (1)
Isocyanide Derivatives of Polysaccharides as Supports for Enzyme Immobilization (1978) (1)
Synthesis of tritiated poly‐L‐lysine (γ, δ‐T2) (1964) (1)
Drugs affecting the cholinergic system in the intact mammalian eye. I. Evaluation of the miotic activity of acetylcholine-like drugs in the mouse eye. (1975) (1)
Proceedings: Synthesis of alpha-N-tosyl-p-guanidino-L-phenylalanine methyl ester and its interaction with trypsin, thrombin and chymotrypsin. (1975) (1)
A rapid method for measuring miotic activity of drugs in the intact mouse eye. (1975) (1)
Structure-activity relationship in a new series of atropine analogs. II. The effect of an asymmetric N-substituent on the antimuscarinic activity. (1978) (1)
Mechanistic implications of cyanide binding to carboxypeptidase B. (2009) (1)
Tyrosyl interactions at the active site of carboxypeptidase B. (2009) (0)
Subject Index Vol. 40, 1985 (1985) (0)
Molecular regulation of receptors : Interaction of ( 3-estradiol and progesterone with the muscarinic system ( cholinergic receptor / sex hormone / receptor communication ) (0)
Full details concerning homogenate preparations are in [5,6]. Direct binding ofN-[3H] methyl-4-piper- idyl benzilate to muscarinic receptors, as well as com- petition experiments with agonists, in homogenates (2001) (0)
STRUCTURE-ACTIVITY RELATIONSHIP IN A NEW SERIES OF ATROPINE ANALOGS. 1. N,N′-DISUBSTITUTED 6,7-DIAZABICYCLO(3.2.2)NONANE DERIVATIVES (1979) (0)
881 – TRICYCLIC ANTIDEPRESSANTS AND THE MUSCARINIC RECEPTOR IN THE CENTRAL NERVOUS SYSTEM (1978) (0)
Dexanabinol derivatives and compositions their use as neuroprotective pharmaceutical (1995) (0)
Numerical technique using a digital computer for the determination of the specificity of proteolytic enzymes and chemical cleavages (1971) (0)
Contents, Vol. 18, 1982 (1978) (0)
Subject Index, Vol. 18, 1982 (1978) (0)
The Mechanism of Interaction of Oximes with the Muscarinic Cholinergic Complex in the Central Nervous System. (1985) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Mordechai. Sokolovsky?

Mordechai. Sokolovsky is affiliated with the following schools:

Tel Aviv University